← All organizations

Novartis

For profitContributed to NMEWebsite ↗

Also known as: AAA USA NOVARTIS | Advanced Accelerator Applications, a Novartis company | Alcon, a Novartis Company | Basel Novartis Pharma AG | Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | Norvartis Pharma, Nuremberg, Germany | Novartiis Pharmaceuticals | Novartis | NOVARTIS | Novartis AG | Novartis Argentina | Novartis Australia | Novartis Austria | Novartis Basel | Novartis Basel +41 61 324 1111 | Novartis Basel+ 41 61 324 1111 | Novartis Basel, Switzerland | Novartis Belgium | Novartis Brazil | Novartis Consumer Health | Novartis Czech Republic | Novartis Denmark | Novartis de Venezuela | Novartis Farma S.p.A. | Novartis Finland | Novartis Gene Therapies, Inc. | Novartis Germany | Novartis Great Britian | Novartis Hungary | Novartis Iceland | Novartis - Including Sites in Germany | Novartis India Ltd. | Novartis Institute for BioMedical Research | Novartis Institute for Tropical Medicine | Novartis Institutes for BioMedical Research | Novartis Institutes for BioMedical Research, Inc. | Novartis Institutes of Biomedical Research | Novartis Investigative | Novartis investigative site | Novartis Investigative Site | Novartis investigator site | Novartis Investigator Site | Novartis Ireland Ltd | Novartis Italy | Novartis Korea Ltd. | Novartis Medical Nutrition | Novartis Norway | NOVARTIS PHARM | Novartis Pharma AG, Basel | Novartis Pharma AG Basel, Switzerland | Novartis Pharma AG, Basel, Switzerland | Novartis Pharma AG, Switzerland | Novartis Pharma B.V. | Novartis Pharmaceutcals | Novartis Pharmaceutical | Novartis Pharmaceuticals | Novartis Pharmaceuticals, Basel +41 61 324 1111. | Novartis Pharmaceuticals Canada | Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation (Financial supporter) | Novartis Pharmaceuticals Japan | Novartis Pharmaceuticals, Japan | Novartis Pharmaceuticals UK Limited | Novartis Pharmaceuticasl | Novartis Pharmaceuticlas | Novartis Pharmacuticals | Novartis Pharma K.K. | Novartis Pharmceuticals | Novartis Pharmeceuticals | NOVARTIS PHARMS | NOVARTIS PHARMS CORP | Novartis Poland | Novartis Portugal | Novartis Romania | Novartis Russia | Novartis / Schering AG Germany | Novartis / Schering AG, Germany | Novartis Slovakia | Novartis South Africa | Novartis Spain | Novartis Sverige AB | Novartis Sweden | Novartis United Kingdom | Novartis Vaccines | Novartis Vaccines and Diagnostics (formerly Chiron Vaccines) | Novartis Vaccines and Diagnostics GmbH & Co KG., Germany | Novartis Vaccines and Diagnostics, Inc | Novartis Vaccines and Diagnostics S.r.l. | Novartis Vaccines & Diagnostics | Novartitis Pharmaceuticals | Novarts Pharmaceuticals | Novatis Pharmaceuticals | The Novartis Foundation

Highest phase reached

Phase 4

First clinical trial

Jan 1, 1996

First marketed drug

Jan 1, 1996

First NDA

May 28, 1996

Last known activity

Jun 29, 2026

Timeline

1990s

  1. Jan 1, 1996

    Novartis— Founded

  2. Jan 1, 1996

    Ciba-Geigy— Acquired

  3. Jan 1, 1996

    SandozSandoz— Acquired

  4. Feb 1, 1997

    Systemix— Acquired

2000s

  1. Apr 21, 2000

    rivastigmine— NDA Organization

  2. Jan 1, 2002

    Lek Pharmaceuticals— Acquired

  3. Jan 1, 2002

    Sabex Holdings— Acquired

  4. Jan 1, 2005

    Eon Labs— Acquired

  5. Jan 1, 2005

    Hexal AG— Acquired

  6. Jan 1, 2006

    Chiron— Acquired

  7. Apr 6, 2007

    cefdinir— Marketing Organization

  8. Jan 1, 2008

    Protez Pharmaceuticals— Acquired

  9. Jul 10, 2008

    Speedel Pharma Ltd.— Acquired

  10. Jan 1, 2009

    Corthera— Acquired

2010s

  1. Jan 1, 2012

    Fougera— Acquired

  2. Apr 19, 2013

    brimonidine— NDA Secondary Org

  3. Oct 22, 2013

    Sideris Pharmaceuticals— Acquired

  4. Jan 1, 2014

    CoStim Pharmaceuticals— Acquired

  5. Jan 1, 2015

    Admune Therapeutics— Acquired

  6. Jan 1, 2015

    Spinifex Pharmaceuticals— Acquired

  7. Oct 18, 2016

    Endocyte— Acquired

  8. Nov 21, 2016

    Selexys Pharmaceuticals Corporation— Acquired

  9. Dec 16, 2016

    Ziarco Pharma Ltd— Acquired

  10. Dec 20, 2016

    Encore Vision, Inc.— Acquired

  11. Jan 22, 2018

    Advanced Accelerator Applications— Acquired

  12. Apr 9, 2018

    AveXis, Inc.— Acquired

  13. Apr 1, 2019

    IFM Tre— Acquired

  14. Nov 25, 2019

    The Medicines CompanyThe Medicines Company— Acquired

2020s

  1. Dec 17, 2020

    Cadent TherapeuticsCadent Therapeutics— Acquired

  2. Apr 7, 2021

    Artios— Acquired

  3. Dec 22, 2021

    Gyroscope Therapeutics— Acquired

  4. Aug 23, 2022

    Aerie Pharmaceuticals— Acquired

  5. Jun 12, 2023

    Chinook Therapeutics— Acquired

  6. Jul 17, 2023

    DTX— Acquired

  7. Feb 6, 2024

    MorphoSys— Acquired

  8. Feb 11, 2025

    Anthos Therapeutics, Inc.— Acquired

  9. Apr 30, 2025

    Regulus Therapeutics Inc.— Acquired

  10. Sep 9, 2025

    Tourmaline Bio— Acquired

  11. Dec 1, 2025

    Avidity Biosciences, Inc.— Acquired

Drugs by trial phase (979 distinct, 4756 trials)

Indications

Approved for

Studied for

Marketed drugs (380)

Subsidiaries (35 direct, 64 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Basel, CH Jan 1, 1996
First NDA
May 28, 1996
Last known activity
Jun 29, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy
  • Accelerated approval